Outside of its pain-relieving outcomes, conolidine has shown a favorable basic safety margin in preclinical toxicology assessments. Unlike opioids, which often result in respiratory depression at greater doses, conolidine has not produced indications of sizeable respiratory suppression. In addition, behavioral assessments in murine models advise an absence of drug-looking https://jasony702awr0.blogofchange.com/profile